Brief: Spago Nanomedical Q2 Sales at SEK 114 Thousand

Spago Nanomedical AB (publ)

31/07/2023 08:04

Jul 31 (Reuters) - Spago Nanomedical Q2 net income SEK -7.866 million.
* Q2 adjusted EPS SEK -0.09
* Q2 sales SEK 114 thousand
* Q2 operating expenses SEK -10.982 million